According to a new report published by Allied Market Research, titled, “Heparin Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021–2028,” the global heparin market size was valued at $6,535 million in 2020, and is projected to reach $11,015 million by 2028, registering a CAGR of 6.6% from 2021 to 2028.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫: https://www.alliedmarketresearch.com/request-sample/6551
The major factor that boosts the growth of the heparin market includes increase in the incidence of venous thrombosis as a result of various underlying factors such as cardiovascular diseases. Furthermore, the use of heparin in a variety of operations, such as orthopaedic and cardiac surgeries, as well as an increase in the number of patients undergoing such procedures is driving the market growth. However, many negative side effects associated with heparin, such as heparin-induced thrombocytopenia, limit the market growth. Furthermore, since heparin is extracted from animal sources, it raises major safety and supply concerns, which also hinder the growth of the market. In contrast, the availability of synthetic and semi-synthetic heparin mimetics that aid in the treatment of various cancers, coagulation, and inflammatory diseases is expected to provide lucrative opportunities for heparin product adoption. Furthermore, increased government support for healthcare infrastructure improvements and robust R&D initiatives to produce heparin with enhanced therapeutic potential and reduced side effects are expected to create lucrative opportunities for the industry.
COVID-19 Impact Analysis:
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has helped the industry grow significantly, as the demand for heparin has increased, as it helps to control respiratory inflation and thin the blood of those at risk of a blood clot as well as all patients admitted to the hospital with (suspected) COVID-19 treated with prophylactic-dose low-molecular-weight heparin. This supports the heparin market to gain traction during the forecast period.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/6551
The heparin market is segmented on the basis of product, application, distribution channel, and region. By product, the market is divided into unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). Presently, the low molecular weight heparin segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. The key factors such as longer and more predicable activity than UFH and rise in demand for low molecular weight heparin products in hospitalized patients suffering from venous thromboembolism boost the growth of heparin market.
- The study provides an in-depth analysis of the global heparin market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the heparin market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2028 is provided to enable the stakeholders to capitalize on the prevailing heparin market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of heparin used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/6551
The key market players profiled in the report include Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Leo Pharma A/S, Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.
Asia-Pacific is expected to exhibit the fastest growth rate during the forecast period, owing to constantly expanding healthcare infrastructure, presence of untapped resources, economic development, and increasing initiatives by private & public organizations, which are projected to drive the growth of the heparin market in emerging countries in Asia-Pacific. In addition, larger patient pool for cardiovascular diseases and an increase in the aging population are some factors, which drive the growth of the market. Moreover, increase in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the heparin market in the region.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Centrifuge Market: https://www.alliedmarketresearch.com/centrifuge-market-A08418
Biopharmaceutical Excipients Market: https://www.alliedmarketresearch.com/biopharmaceutical-excipients-market-A07450
Sleep Apnea Diagnostics Market: https://www.alliedmarketresearch.com/sleep-apnea-diagnostics-market
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
5933 NE Win Sivers Drive
205, Portland, OR 97220
Toll Free: 1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060